Real-world study of the effectiveness of BBIBP-CorV (Sinopharm) COVID-19 vaccine in the Kingdom of Morocco

Yaowen Zhang, Jihane Belayachi, Yunkai Yang, Qiang Fu, Lance Rodewald, Hongling Li, Bing Yan, Ying Wang, Yanna Shen, Qian Yang, Weiyun Mu, Rong Tang, Chen Su, Tianfang Xu, Majdouline Obtel, Abdelkader Mhayi, Rachid Razine, Redouane Abouqal, Yuntao Zhang, Xiaoming Yang
doi: https://doi.org/10.1101/2022.04.23.22274112

Article Information

doi 
https://doi.org/10.1101/2022.04.23.22274112
History 
  • April 27, 2022.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Yaowen Zhang, MSc1,*,
  2. Jihane Belayachi, MD, PhD2,3,*,
  3. Yunkai Yang, MSc1,*,
  4. Qiang Fu, EMBA4,*,
  5. Lance Rodewald, MD5,
  6. Hongling Li, MD1,
  7. Bing Yan, MSc4,
  8. Ying Wang, PhD4,
  9. Yanna Shen, BS1,
  10. Qian Yang, MD1,
  11. Weiyun Mu, MSc1,
  12. Rong Tang, MSc1,
  13. Chen Su, Dipl. Ing.4,
  14. Tianfang Xu, MA1,
  15. Majdouline Obtel, PhD3,6,
  16. Abdelkader Mhayi, PhD7,
  17. Rachid Razine, PhD3,6,
  18. Redouane Abouqal, MD2,3,#,
  19. Yuntao Zhang, PhD1,# and
  20. Xiaoming Yang, MD1,#
  1. 1China National Biotec Group Company Limited, Beijing, P.R. China
  2. 2Acute Medical Unit, Ibn Sina University Hospital, 10000, Rabat, Morocco
  3. 3Laboratory of Biostatistics, Clinical, and Epidemiological Research, Department of Public Health, Faculty of Medicine and Pharmacy-Mohamed V University in Rabat, Morocco
  4. 4China Sinopharm International Corporation, Beijing, P.R. China
  5. 5National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing, P.R. China
  6. 6Laboratory of Community Health (Public Health, Preventive Medicine and Hygiene) Department of Public Health, Faculty of Medicine and Pharmacy-Mohamed V University in Rabat, Morocco
  7. 7Department of informatics; Ministry of health and social protection, Rabat, Morocco
  1. ↵#Corresponding Author: Xiaoming Yang, China National Biotec Group Company Limited, B2 Shuangqiao Rd, Chaoyang District, Beijing, China (yangxiaoming{at}sinopharm.com); Yuntao Zhang, China National Biotec Group Company Limited, B2 Shuangqiao Rd, Chaoyang District, Beijing, China (zhangyuntao{at}sinopharm.com); Redouane Abouqal, Acute Medical Unit, Ibn Sina University Hospital, 10000, Rabat, Morocco; Laboratory of Biostatistics, Clinical, and Epidemiological Research, Department of Public Health, Faculty of Medicine and Pharmacy-Mohamed V University in Rabat, Morocco (r.abouqal{at}um5r.ac.ma).

  1. ↵* Authors contributed equally to this study.

Back to top
Posted April 27, 2022.
Download PDF
Data/Code
Email
Real-world study of the effectiveness of BBIBP-CorV (Sinopharm) COVID-19 vaccine in the Kingdom of Morocco
Yaowen Zhang, Jihane Belayachi, Yunkai Yang, Qiang Fu, Lance Rodewald, Hongling Li, Bing Yan, Ying Wang, Yanna Shen, Qian Yang, Weiyun Mu, Rong Tang, Chen Su, Tianfang Xu, Majdouline Obtel, Abdelkader Mhayi, Rachid Razine, Redouane Abouqal, Yuntao Zhang, Xiaoming Yang
medRxiv 2022.04.23.22274112; doi: https://doi.org/10.1101/2022.04.23.22274112
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area